Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alexander Muik

18PUBLICATIONS

87CO-AUTHORS

Evolution of developmental systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Agricultural molecular engineering of nucleic acids and proteinsInnate immunityGenetically modified animals

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Dec 05, 2025

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines.

Wei Chen, Kristin R Tompkins, Ian W Windsor

|Jul 16, 2025

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Uğur Şahin, Alexander Muik, Isabel Vogler

|Nov 20, 2024

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine.

Kayvon Modjarrad, Ye Che, Wei Chen

|Nov 15, 2022

Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.

Alexander Muik, Bonny Gaby Lui, Maren Bacher

|Sep 20, 2022

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.

Alexander Muik, Bonny Gaby Lui, Maren Bacher

|Jun 23, 2022

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.

Chaitanya Kurhade, Jing Zou, Hongjie Xia

Pageof 3

Frequent Collaborators

12 joint publications

Ugur Sahin

9 joint publications

Kena A Swanson

8 joint publications

Pei-Yong Shi

6 joint publications

Philip R Dormitzer

5 joint publications

Isabel Vogler

5 joint publications

Mathias Vormehr

5 joint publications

Jasmin Quandt

4 joint publications

Kristen Pascal

4 joint publications

Rolf Hilker

4 joint publications

Martin Bexon

Frequent Collaborators

12 joint publications

Ugur Sahin

9 joint publications

Kena A Swanson

8 joint publications

Pei-Yong Shi

6 joint publications

Philip R Dormitzer

Top Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine <em>via</em> the Flow Cytometry Technique

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine <em>via</em> the Flow Cytometry Technique

Published on : Sep 23, 2022

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

See more related videos

Top Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine <em>via</em> the Flow Cytometry Technique

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine <em>via</em> the Flow Cytometry Technique

Published on : Sep 23, 2022

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

See more related videos